|
|
Vol. 15.06 – 16 February, 2024
|
|
|
|
|
|
|
|
Mechanistically, monoamine oxidase B (MAOB) induced a reactive stroma with activated marker expression, increased extracellular matrix remodeling, and acquisition of a protumorigenic phenotype through enhanced production of reactive oxygen species. [Science Advances]
|
|
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal
|
|
|
|
|
|
Researchers identified BRPF reader proteins, along with several epigenetic groups that acted as targets effectively reversing the resistance mediated by ABCB1. [Cell Death & Disease]
|
|
|
|
|
|
The authors explored the prevalence of germline genetic mutations in men with metastatic castration-resistant prostate cancer recruited to the BARCODE2 trial.
[British Journal Of Cancer]
|
|
|
|
|
|
Investigators downloaded prostate cancer single-cell sequencing data and second-generation sequencing data from multiple public databases. From these data, they identified characteristic genes associated with tumor-associated macrophages clusters.
[Cancer Immunology Immunotherapy]
|
|
|
|
|
|
Investigators used LuCaP patient-derived xenograft tumors, clinically relevant models that reflects and retains key features of the tumor from advanced prostate cancer patients.
[Molecular Cancer Research]
|
|
|
|
|
|
The authors characterized a small-molecule agonist named aNDR1, which specifically bound to Nuclear Dbf2-related kinase 1 (NDR1) and potently promoted NDR1 expression, enzymatic activity and phosphorylation.
[Frontiers In Pharmacology]
|
|
|
|
|
|
Investigators discovered pronounced hypoxia in primary lesions of metastatic prostate cancer (mPCa). The exosomes secreted by cancer-associated fibroblasts under hypoxic conditions significantly enhance PCa metastasis both in vitro and in vivo.
[Cancer Gene Therapy]
|
|
|
|
|
|
CALGB 90401 (Alliance) was a Phase III trial of 1050 patients with metastatic castration-resistant prostate cancer comparing docetaxel, prednisone, bevacizumab (DP+B) versus DP alone.
[Prostate Cancer And Prostatic Diseases]
|
|
|
|
|
|
Investigators built an in silico model combining Alphafold2 and all-atom molecular dynamics to understand and predict an optimal hinge amino acid sequence length for a given single-chain variable fragment targeting a specific cancer antigen. [Biophysical Journal]
|
|
|
|
|
|
|
|
Scientists summarize the current evidence indicating that aberrant or dysregulated N6‐methyladenosine modification is associated with urological cancer development, progression and prognosis. [Nature Reviews Urology]
|
|
|
|
|
|
|
|
Dr. Taran Gujral and his lab created a drug-matching platform that uses artificial intelligence to help researchers, clinicians and, most importantly, patients find additional uses for drugs that have already gone through clinical trials and received approval from the US FDA.
[Fred Hutch Cancer Center]
|
|
|
|
|
|
Infections after a prostate biopsy are rare, but they do occur. Now research shows that fewer than 2% of men develop confirmed infections after prostate biopsy, regardless of the technique used. [Harvard Health Publishing]
|
|
|
|
|
|
|
|
April 5 – 8, 2024 Paris, France
|
|
|
|
|
|
|
|
|
|
|
UC Davis – Davis, California, United States
|
|
|
|
|
|
|
Cyprus Cancer Research Institute – Aglandjia, Cyprus
|
|
|
|
|
|
|
Cyprus Cancer Research Institute – Aglandjia, Cyprus
|
|
|
|
|
|
|
University of Texas MD Anderson Cancer Center – Houston, Texas, United States
|
|
|
|
|
|
|
University of Birmingham – Birmingham, England, United Kingdom
|
|
|
|
|
|